Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT06865885Phase 4Recruiting
LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering
Cardiometabolic SyndromeDrug InteractionsLDL-Cholersterol Lowering+1 more
StudydirectorStart date: 2025-04-02

Research Network

Collaboration Network

16 collaborators·18 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, San Diego

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Eric D Adler, MD

University of California, San Diego

Moderately Similar
2 trials

Shared therapeutic areas:

Cardiometabolic SyndromeDrug InteractionsLDL-Cholersterol Lowering+1 more

Worked with same sponsors:

NovartisUniversity of California, San Diego
Collaborated on 1 trial
Similarity Score44%

Pam Taub, MD

University of California, San Diego

Moderately Similar
5 trials

Shared therapeutic areas:

Cardiometabolic SyndromeDrug InteractionsLDL-Cholersterol Lowering+1 more

Worked with same sponsors:

NovartisUniversity of California, San Diego
Collaborated on 1 trial
Similarity Score44%

Michael Wilkinson, MD

University of California, San Diego

Moderately Similar
1 trials

Shared therapeutic areas:

Cardiometabolic SyndromeDrug InteractionsLDL-Cholersterol Lowering+1 more

Worked with same sponsors:

NovartisUniversity of California, San Diego
Collaborated on 1 trial
Similarity Score44%

Rita Jain, MD

Abbott

Related
6 trials

Shared therapeutic areas:

Drug Interactions
Similarity Score8%

Joel Neutel, MD

Orange County Research Center

Related
11 trials

Shared therapeutic areas:

Cardiometabolic Syndrome
Similarity Score8%

Damien PAINEAU, MS

Nutri-Health, Rueil-Malmaison, France

Related
1 trials

Shared therapeutic areas:

Primary Prevention
Similarity Score8%

Suman Wason, MD

Lexicon Pharmaceuticals, Inc.

Related
23 trials

Shared therapeutic areas:

Drug Interactions
Similarity Score8%

Brian Tomlinson, MD

Chinese University of Hong Kong

Related
4 trials

Shared therapeutic areas:

Drug Interactions
Similarity Score8%

Yurdaguel Zopf, Prof.

University Erlangen Nuremberg Medical School

Related
6 trials

Shared therapeutic areas:

Primary Prevention
Similarity Score8%

Dejan Reljic, Dr.

University Erlangen Nuremberg Medical School

Related
7 trials

Shared therapeutic areas:

Primary Prevention
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06865885Phase 4StudyDirector

LDL-C Optimization Using Inclisiran in Patients in Which Drug-Drug Interactions Limit LDL Lowering

Cardiometabolic SyndromeDrug InteractionsLDL-Cholersterol Lowering+1 more
Recruiting

All 1 trials loaded